Algert Global’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.56M Buy
1,021,280
+136,680
+15% +$1.28M 0.2% 140
2025
Q1
$10.9M Buy
884,600
+98,968
+13% +$1.22M 0.27% 82
2024
Q4
$10.4M Buy
785,632
+310,634
+65% +$4.11M 0.24% 99
2024
Q3
$9.14M Buy
474,998
+42,870
+10% +$825K 0.25% 95
2024
Q2
$8.87M Buy
432,128
+6,455
+2% +$133K 0.3% 61
2024
Q1
$10.1M Sell
425,673
-102,484
-19% -$2.44M 0.4% 35
2023
Q4
$11.4M Buy
528,157
+71,938
+16% +$1.55M 0.46% 13
2023
Q3
$6.62M Buy
456,219
+202,588
+80% +$2.94M 0.31% 67
2023
Q2
$5.31M Buy
253,631
+167,660
+195% +$3.51M 0.23% 104
2023
Q1
$1.82M Buy
85,971
+8,191
+11% +$173K 0.09% 381
2022
Q4
$1.98M Buy
77,780
+28,880
+59% +$735K 0.11% 300
2022
Q3
$1.18M Sell
48,900
-5,814
-11% -$140K 0.07% 471
2022
Q2
$1.05M Buy
54,714
+13,180
+32% +$254K 0.08% 448
2022
Q1
$722K Buy
41,534
+9,948
+31% +$173K 0.05% 666
2021
Q4
$691K Buy
+31,586
New +$691K 0.09% 420
2021
Q2
Sell
-9,550
Closed -$214K 520
2021
Q1
$214K Sell
9,550
-18,020
-65% -$404K 0.07% 366
2020
Q4
$613K Buy
27,570
+8,440
+44% +$188K 0.17% 191
2020
Q3
$282K Buy
19,130
+8,350
+77% +$123K 0.09% 268
2020
Q2
$160K Sell
10,780
-11,800
-52% -$175K 0.05% 346
2020
Q1
$248K Sell
22,580
-3,000
-12% -$33K 0.1% 278
2019
Q4
$225K Buy
25,580
+8,110
+46% +$71.3K 0.07% 300
2019
Q3
$131K Buy
17,470
+1,600
+10% +$12K 0.05% 308
2019
Q2
$148K Buy
+15,870
New +$148K 0.05% 302
2018
Q3
Sell
-73,499
Closed -$516K 382
2018
Q2
$516K Buy
+73,499
New +$516K 0.11% 241